DOI: 10.1200/po.23.00677 ISSN: 2473-4284

CNS Antitumor Activity of Amivantamab With Osimertinib in Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer With Acquired Mesenchymal-Epithelial Transition Amplification Resistance Mechanism: A Case Report

Ebaa Al-Obeidi, Karen Kelly, David R. Gandara, Jonathan W. Riess
  • Cancer Research
  • Oncology

NSCLC w/EGFRex19del & MET amp: durable intracranial + systemic response to amivantamab/osimertinib

More from our Archive